Oct. 17, 2019
NeoProgen, a Baltimore-based company led by medtech entrepreneur Bill Niland, raised $1.5 million in seed funding as it develops a cell therapy for patients following a heart attack.
October 16, 2019
NeoProgen, Inc., a preclinical stage therapeutics company located in Baltimore, has received a $245,000 investment from the University System of Maryland (USM) Maryland Momentum Fund to complete the company’s $1.5M seed funding round, which also includes participation from UMB, TEDCO (Maryland Venture Partners, L.P.) and UM Ventures.
September 10, 2019
The Maryland Stem Cell Research Commission has awarded $1.35 million through five grants as part of the commission’s first round of funding for the fiscal year, the commission announced Tuesday.
Jun 27, 2019
Bill Niland has led multiple medical device companies throughout his career, and was the CEO behind the $250 million sale of Baltimore's Harpoon Medical in 2017. Now, he is working to build three more device companies here, with hopes to lead all of them through similar exits.